Immediate Impact
55 standout
Citing Papers
Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy
2024 Standout
H2AX: A key player in DNA damage response and a promising target for cancer therapy
2024 Standout
Works of Rouzbeh Chegeni being referenced
MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies
2021
Utilization of CRISPR/Cas9 gene editing in cellular therapies for lymphoid malignancies
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Rouzbeh Chegeni | 214 | 175 | 106 | 24 | 407 | |
| Henning D. Popp | 177 | 135 | 71 | 31 | 420 | |
| Yuxia Zhan | 150 | 199 | 77 | 20 | 414 | |
| M. Dörner | 232 | 166 | 49 | 15 | 418 | |
| Sanne Hiddingh | 153 | 162 | 123 | 20 | 364 | |
| Maged S. Mahmoud | 198 | 159 | 131 | 14 | 364 | |
| I Junghahn | 81 | 209 | 128 | 23 | 448 | |
| W.R. Gerritsen | 144 | 116 | 124 | 20 | 366 | |
| Klaus Lennartz | 94 | 183 | 103 | 23 | 426 | |
| JK Brennan | 173 | 122 | 60 | 16 | 388 | |
| Aage Drivsholm | 256 | 110 | 76 | 23 | 355 |
All Works
Loading papers...